18 results Discover our SPC booklet Our Brussels IP/Life Sciences team has authored a booklet on the case-law of the Court of justice of the EU (CJEU) regarding supplementary protection certificates (SPCs). Nynke Brouwer new senior associate at Stibbe We are pleased to announce that Nynke Brouwer will be joining Stibbe’s Amsterdam office as senior associate. Her appointment as from 13 June 2022 will further strengthen our TMT/IP practice. Stibbe advises Avista Capital Partners Stibbe advised Avista Capital Partners in the acquistion of a 50% stake in Vision Healthcare. Louis Bidaine Associate Brussels Philippe Campolini Partner Brussels Vince Van der Wangen Associate Brussels Ignace Vernimme Partner Brussels Nathan Thys Junior Associate Brussels Mari Muzashvili Junior Associate Brussels Anya Murphy Junior Associate Brussels Webinar: The contraversial Bayer judgment and its potential impact on patent litigation in Europe Philippe Campolini, IP partner at Stibbe in Brussels, acts as panelist in a webinar organised by EPLAW (the European Patent Lawyers Association) on the contraversial Bayer judgment and its potential impact on patent litigation in Europe. Stibbe advises pharmaceutical multinational Stibbe assisted a pharmaceutical multinational in complex litigations. Kate Criel Junior Professional Support Lawyer Brussels Stibbe advises group of investors led by Joh. A. Benckiser Stibbe advised a group of investors led by Joh. A. Benckiser on its bid for all outstanding shares of D.E MASTER BLENDERS 1753 N.V. Stibbe advises Rhône Capital Stibbe advised Rhône Capital on its acquisition - and on the financing, tax, IP and employment aspects - of CSM’s Bakery Supplies business for an enterprise value of EUR 1,05 billion. Stibbe advised the shareholders of Punch Powertrain Stibbe advised the shareholders of Punch Powertrain, which include GIMV, LRM, Capricorn, and PMV, and the management, in relation to the EUR 1 billion sale of their shares to the China based Yinyi Group. Stibbe advises biotech company Stibbe advised a leading biotechnology company on the legal aspects of clinical trials development for biotech medicinal products. Stibbe advises major pharmaceutical company Stibbe assisted a global innovative pharmaceutical company in a complex co-marketing and co-promotion agreement and advised it on the impact of an innovative product’s registration at the European Medicines Agency.
Discover our SPC booklet Our Brussels IP/Life Sciences team has authored a booklet on the case-law of the Court of justice of the EU (CJEU) regarding supplementary protection certificates (SPCs).
Nynke Brouwer new senior associate at Stibbe We are pleased to announce that Nynke Brouwer will be joining Stibbe’s Amsterdam office as senior associate. Her appointment as from 13 June 2022 will further strengthen our TMT/IP practice.
Stibbe advises Avista Capital Partners Stibbe advised Avista Capital Partners in the acquistion of a 50% stake in Vision Healthcare.
Webinar: The contraversial Bayer judgment and its potential impact on patent litigation in Europe Philippe Campolini, IP partner at Stibbe in Brussels, acts as panelist in a webinar organised by EPLAW (the European Patent Lawyers Association) on the contraversial Bayer judgment and its potential impact on patent litigation in Europe.
Stibbe advises pharmaceutical multinational Stibbe assisted a pharmaceutical multinational in complex litigations.
Stibbe advises group of investors led by Joh. A. Benckiser Stibbe advised a group of investors led by Joh. A. Benckiser on its bid for all outstanding shares of D.E MASTER BLENDERS 1753 N.V.
Stibbe advises Rhône Capital Stibbe advised Rhône Capital on its acquisition - and on the financing, tax, IP and employment aspects - of CSM’s Bakery Supplies business for an enterprise value of EUR 1,05 billion.
Stibbe advised the shareholders of Punch Powertrain Stibbe advised the shareholders of Punch Powertrain, which include GIMV, LRM, Capricorn, and PMV, and the management, in relation to the EUR 1 billion sale of their shares to the China based Yinyi Group.
Stibbe advises biotech company Stibbe advised a leading biotechnology company on the legal aspects of clinical trials development for biotech medicinal products.
Stibbe advises major pharmaceutical company Stibbe assisted a global innovative pharmaceutical company in a complex co-marketing and co-promotion agreement and advised it on the impact of an innovative product’s registration at the European Medicines Agency.